价格

CRTH2 antagonist

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Compounds having CRTH2 antagonist activity
- US 7750027 B2
  申请人: OXAGEN LTD优先权: 2009
  US
  10 件公开
- US 7999119 B2
  申请人: OXAGEN LTD优先权: 2006
  EP
  US
  5 件公开
- US 8168673 B2
  申请人: ARMER RICHARD EDWARD优先权: 2008
  US
  2 件公开
- CN 1867547 A
  申请人: OXAGEN LTD优先权: 2003
  CN
- US 2007232681 A1
  申请人: OXAGEN LTD优先权: 2003
  US
- CN 101506159 B
  申请人: OXAGEN LTD优先权: 2007
  CN
- US 2009186923 A1
  申请人: ARMER RICHARD EDWARD优先权: 2008
  US
- US 2010022613 A1
  申请人: OXAGEN LTD优先权: 2008
  US
Amine salts of a CRTH2 antagonist
US 8278310 B2申请人: LY TAI WEI优先权: 2007
CN
US
5 件公开
Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents
US 8273745 B2申请人: TERASAKA TADASHI优先权: 2006
CN
US
4 件公开
Particulates of a CRTH2 antagonist
US 8507005 B2申请人: LY TAI WEI优先权: 2007
CN
US
4 件公开
New Combination 665
US 2008242649 A1申请人: CADOGAN ELAINE BRIDGET优先权: 2007
CN
US
3 件公开
Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
US 8969350 B2申请人: COOPER ANNE ELIZABETH优先权: 2009
US
3 件公开
Use of CRTH2 antagonist compounds in therapy
EP 2060258 A1申请人: OXAGEN LTD优先权: 2004
CN
EP
2 件公开
PYRROLE DERIVATIVES HAVING CRTH2 RECEPTOR ANTAGONIST ACTIVITY
US 2010087432 A1申请人: ADCOCK CLAIRE优先权: 2004
CN
US
2 件公开
Salts with CRTH2 Antagonist Activity
US 2010056544 A1申请人: OXAGEN LTD优先权: 2006
CN
US
2 件公开
COMBINATION 408
US 2010144606 A1申请人: ASTRAZENECA AB优先权: 2009
CN
US
2 件公开

药物

CRTH2 antagonist

专利

Compounds having CRTH2 antagonist activity